Some retrospective investigations, for example, by Mancini et al. [39], have demonstrated a decreased risk of hospitalization in statin-treated COPD patients who also received treatment with ACE inhibitors and/or ARBs. This evidence concerns the gene ACE and chronic obstructive pulmonary disease.